Molly Redden, The Guardian

Subpoenas issued by a special US House panel could create a chilling effect for medical research, as the targets balk at the investigation’s wide dragnet

In a move that could sharply undercut efforts to limit abortion by medication, the US Food and Drug Administration on Wednesday announced that it had approved new labeling for the country’s most widely used abortion drug, mifepristone, to better reflect what scientific research shows is the most effective way to use the drug.

The woman inside the ambulance was miscarrying. That was clear from the foul-smelling fluid leaving her body. As the vehicle wailed toward the hospital, a doctor waiting for her arrival phoned a specialist, who was unequivocal: the baby would die. The woman might follow. Induce labor immediately.

Potential measures include expensive new requirements on clinics offering abortions after first trimester and restrictions on Planned Parenthood

Texas’s aggressive campaign to defund Planned Parenthood has led to a steep drop-off in access to popular forms of contraceptives for poor women, and, for some women, a 27% increase in births, a new study published in the New England Journal of Medicine has found.